NewEdge Advisors’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

NewEdge Advisors’s Portfolio FTXH Stock Details FTXH Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$616K	Buy
2023 Q4	–	Sell
2023 Q3	$186K	Buy
2023 Q2	$177K	Sell
2023 Q1	$200K	Buy
2022 Q4	$172	Buy